Skip to main content
Clinical Trials/NCT00918658
NCT00918658
Terminated
N/A

Collection of Bone Marrow and Peripheral Blood for Testing of Notch-induced Natural Killer Cell Activity

Case Comprehensive Cancer Center1 site in 1 country34 target enrollmentApril 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Leukemia
Sponsor
Case Comprehensive Cancer Center
Enrollment
34
Locations
1
Primary Endpoint
Collection of normal and malignant cells to use as target cells in cytotoxicity assays
Status
Terminated
Last Updated
10 years ago

Overview

Brief Summary

RATIONALE: Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors find better ways to treat the cancer.

PURPOSE: This research study is looking at natural killer cells in bone marrow and blood samples from patients with hematologic cancer and from patients who do not have cancer.

Detailed Description

OBJECTIVES: * To collect normal and malignant cells in bone marrow and peripheral blood samples from patients with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or multiple myeloma and from patients with no malignancy to use as target cells in cytotoxicity assays. * To collect information about HLA type and immunophenotype of malignant cells as determined by clinical flow cytometry. OUTLINE: Bone marrow aspirates and/or peripheral blood samples are collected and used as target cells in standard cytotoxicity assays, with notch-induced natural killer (N-NK) cells as the effector cells, to determine whether N-NK cells are capable of killing malignant cells and/or non-malignant cells. Receptor-blocking antibodies may be added to determine which NK cell receptors are responsible for malignant cell recognition and killing. Information about HLA type and immunophenotype of the malignant cells is collected from the patient's medical record.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
March 2011
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Collection of normal and malignant cells to use as target cells in cytotoxicity assays

Time Frame: We anticipate collecting approximately 30 samples in total, over a 1-2 year period.

Study Sites (1)

Loading locations...

Similar Trials